Xenon Pharmaceuticals Inc. (XENE) Revenue 2015–2025
Xenon Pharmaceuticals Inc. (XENE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.5MFY2025 · since FY2015: $15.6M → $7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.5M | — |
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $9.4M | -48.8% |
| FY2021 | $18.4M | -42.7% |
| FY2020 | $32.2M | +371.0% |
| FY2019 | $6.8M | — |
| FY2017 | $311,000 | -82.8% |
| FY2016 | $1.8M | -88.4% |
| FY2015 | $15.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice